Evaluation of alveolar ridge values with autogenous tooth graft and the provocative venture of allogeneic tooth graft from family members

Abstract

Background Preserving the structural integrity of the alveolar ridge is paramount in ensuring the success of dental implant procedures and optimizing both aesthetic and physiological outcomes. This study aims to evaluate the efficacy of autologous dental grafting and explore intriguing results achieved through the utilization of allogeneic dental grafts obtained from a familial participant within the study’s framework. Methods Eleven patients necessitating bilateral dental extractions were enrolled in the study. Ten patients underwent autologous dental grafting on one side, while the contralateral side remained untreated. In the eleventh case, one side received autogenous dental grafting, while the other side was augmented with an allogeneic graft sourced from the patient’s son. Outcomes were monitored over a four-month period. Results Autogenous dental grafting led to a significant enhancement in bone density values and a reduction in osseous absorption rates(P<0.05) when compared to untreated sites among the ten patients who underwent the procedure. However, notable advancements were observed in patient 11 who received an allogeneic dental graft from a familial donor, suggesting potential superiority over autologous grafting in promoting bone regeneration. These findings underscore the promising prospects of employing allogeneic dental grafts sourced from family members to achieve optimal outcomes in alveolar ridge preservation. Conclusions The study underscores the significance of utilizing autologous dental grafts for preserving alveolar ridge dimensions. Importantly, the noteworthy improvement observed in patient outcomes resulting from the use of allogeneic dental grafts compared to autologous grafts raises several inquiries, particularly concerning the potential relationship between the patient and the donor. Trial registration The study is registered as a BRAZILIAN CLINICAL TEST RECORD (ReBEC): U1111-1305-2793 on 28-05-2024 ( https://ensaiosclinicos.gov.br/rg/RBR-65qchvs).